Active, Not Recruiting
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
NCT02519348
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Research Site Phoenix, Arizona, United States
- Research Site San Francisco, California, United States
- Research Site New Haven, Connecticut, United States
- Research Site Jacksonville, Florida, United States